Yu Han, Zhang Fenghua, Wen Yueqiang, Zheng Zhili, Chen Gaoyang, Pan Yingying, Wu Peijie, Ye Qiaobo, Han Jun, Chen Xiaofeng, Liu Chao, Shen Tao
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Department of Pediatrics, Guang'an Hospital of Traditional Chinese Medicine, Guang'an, China.
Front Pharmacol. 2022 Nov 2;13:1038188. doi: 10.3389/fphar.2022.1038188. eCollection 2022.
Zhuyu pill (ZYP) is a traditional Chinese medicine prescription composed of two drugs, Franch. and (A. Jussieu) T. G. Hartley, and is commonly used in the clinical treatment of diseases of the digestive system. However, the mechanism underlying the effect of ZYP on colitis remains unclear. In this study, a colitis rat model was induced with 2,4,6-trinitro-benzenesulfonic acid (TNBS, 100 mg/kg) and treated with ZYP (low dose: 0.6 g/kg, high dose: 1.2 g/kg). Disease activity index, colonic weight index, and weight change ratio were used to evaluate the model and efficacy. LC-MS and 16S rRNA gene sequencing were used to measure differences in fecal metabolism and microorganism population among the control, model, low-dose ZYP, and high-dose ZYP groups. To elucidate the mechanism of interventional effect of ZYP, Spearman correlation analysis was used to analyze the correlation between fecal metabolism and fecal microbial number. High-dose and low-dose ZYP both exhibited significant interventional effects on colitis rat models, and high-dose ZYP produced a better interventional effect compared with low-dose ZYP. Based on a metabolomics test of fecal samples, significantly altered metabolites in the model and high-dose ZYP treatment groups were identified. In total, 492 metabolites were differentially expressed. Additionally, sequencing of the 16S rRNA gene in fecal samples revealed that the high-dose ZYP could improve TNBS-induced fecal microbiota dysbiosis. Ultimately, changes in tryptophan metabolism and and populations were detected after ZYP treatment in both colitis and cholestasis. Therefore, we conclude that tryptophan metabolism and and populations are the core targets of the anti-inflammatory effect of ZYP. These findings provide a scientific basis for further investigation of the anti-inflammatory mechanism of ZYP in the future.
逐瘀丸(ZYP)是一种由两种药物,即延胡索和(某种植物,此处原文未完整给出植物名称)组成的中药方剂,常用于消化系统疾病的临床治疗。然而,ZYP对结肠炎作用的潜在机制仍不清楚。在本研究中,用2,4,6-三硝基苯磺酸(TNBS,100mg/kg)诱导建立结肠炎大鼠模型,并用ZYP(低剂量:0.6g/kg,高剂量:1.2g/kg)进行治疗。采用疾病活动指数、结肠重量指数和体重变化率来评估模型和疗效。利用液相色谱-质谱联用(LC-MS)和16S rRNA基因测序来检测对照组、模型组、低剂量ZYP组和高剂量ZYP组粪便代谢和微生物群落的差异。为阐明ZYP干预作用的机制,采用Spearman相关性分析来分析粪便代谢与粪便微生物数量之间的相关性。高剂量和低剂量ZYP对结肠炎大鼠模型均表现出显著的干预作用,且高剂量ZYP的干预效果优于低剂量ZYP。基于粪便样本的代谢组学检测,鉴定出模型组和高剂量ZYP治疗组中显著改变的代谢物。总共492种代谢物存在差异表达。此外,粪便样本中16S rRNA基因测序显示,高剂量ZYP可改善TNBS诱导的粪便微生物群失调。最终,在结肠炎和胆汁淤积症中,ZYP治疗后均检测到色氨酸代谢以及(此处原文未完整给出相关内容)种群的变化。因此,我们得出结论,色氨酸代谢以及(此处原文未完整给出相关内容)种群是ZYP抗炎作用的核心靶点。这些发现为未来进一步研究ZYP的抗炎机制提供了科学依据。